Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism HCV NS4B inhibitors(HCV NS4B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis C | Preclinical | United States | 20 Jan 2010 |





